The rotator cuff study was presented at the Orthopaedic Research Society Annual Meeting, Feb. 2-5 in Austin, Texas. Highlighting the results of a dose ranging study, the presentation gave insight into how the study used MRI and histopathology to compare the results of Ortho-R versus standard care options.
Results showed Ortho-R improved rotator cuff healing processes in a large animal model. The study will be published in the Journal of Tissue Engineering and Regenerative Medicine.
Ortho RTi has produced 16 peer-reviewed abstracts, posters, manuscripts and podium presentations in the last two years on its various technologies.
More articles on biologics:
ThermoGenesis makes orthopedic partnership: 3 notes
CDC investigates contaminated stem cell products: 5 things to know
Global spine biologics market to hit $2.7B by 2024 — 18 key players
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
